Evidence map›Paper›PMID 26174493›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Kappa Antagonist JDTic in Phase 1 Clinical Trial.

Charles Chavkin, Diana Martinez

Abstract readComment
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties.Progress in neuro-psychopharmacology & biological psychiatry · 2022
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats.The international journal of neuropsychopharmacology · 2019
    Article
  10. Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Major Depressive Disorder and Kappa Opioid Receptor Antagonists.Translational perioperative and pain medicine
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Charles ChavkinDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, USA.
Diana MartinezDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, NY, USA.

Funding

Using PET to Image the Neurochemistry of AddictionK02DA026525 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARTINEZ, DIANA M · 2009 to 2018
$1.3M
NIDA NIH HHS K02 DA026525
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HumansMalePiperidinesReceptors, Opioid, kappaTachycardia, VentricularTetrahydroisoquinolinesPiperidinesReceptors, Opioid, kappaTetrahydroisoquinolines

Identifiers

PMID26174493
PMCPMC4613619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.